-
-
EMTALA: The Essential Guide to Compliance from Thomson American Health Consultants, publisher of Emergency Medicine Reports, explains how the changes to EMTALA will affect emergency departments and off-campus clinics. In-depth articles, at-a-glance tables, and Q-and-As on real-life situations are presented, and key differences between the "old" EMTALA and the new changes are succinctly explained,
-
What would happen today if a patient with suspect or probable SARS were admitted to your hospital? To help you prepare for the threat, Thomson American Health Consultants offers the upcoming audio conference: The Resurgence of SARS: Why your hospital may not be as prepared as you think, on Dec. 9, from 2:30-3:30 EST. Let our experts help you answer that and many other critical questions with practical tips and solutions to detect first cases and protect other patients and health care workers.
-
-
St Johns Wort and Drug Interactions; Serum Potassium and Stroke Risk Among Hypertensive Adults; Skin Cancer Prevention and Detection Practices Among Siblings of Patients with Melanoma
-
The FDA has approved the first of a new class of antibiotics for the treatment of complicated skin and skin structure infections. Daptomycin is a cyclic lipopeptide that is active against Gram-positive bacteria.
-
The new criterion for FPG will identify many more individuals who are at risk for developing diabetes.
-
Like patients hospitalized with acute myocardial infarction and total knee replacements, EM of hospitalized patients with CAP reduces overall hospital length of stay and institutional resources without increasing the risk of adverse outcomes.
-
More than 90% of individuals studied maintain measurable humoral or T-cell-mediated immunity against vaccinia virus for as long as 75 years after smallpox vaccination.
-
Sleepiness, obesity, hypertension, witnessed apneas, and frequent snoring are prevalent in the general population; demand for diagnostic and treatment services for sleep apnea is likely to skyrocket.